Breaking News Instant updates and real-time market news.

CDEV

Centennial Resource Development

$19.73

0.17 (0.87%)

, CRZO

Carrizo Oil & Gas

$26.46

0.65 (2.52%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55

Tudor Pickering to hold a conference

2018 Hotter n Hell Conference will be held in Houston on May 15-16.

CDEV

Centennial Resource Development

$19.73

0.17 (0.87%)

CRZO

Carrizo Oil & Gas

$26.46

0.65 (2.52%)

HLX

Helix Energy

$8.00

0.04 (0.50%)

OAS

Oasis Petroleum

$11.94

0.135 (1.14%)

OMP

Oasis Midstream Partners

$18.33

-0.02 (-0.11%)

SRCE

1st Source

$52.82

0.3 (0.57%)

  • 16

    May

  • 22

    May

  • 12

    Jun

  • 19

    Aug

CDEV Centennial Resource Development
$19.73

0.17 (0.87%)

03/13/18
03/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altice USA (ATUS) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Brett Feldman citing solid fundamentals and attractive valuation, capital return potential from the spin-off from Altice NV, and overstated concerns regarding rising interest rates on the company's capital structure. 2. Total (TOT) upgraded to Overweight from Equal Weight at Barclays with analyst Lydia Rainforth saying she sees the company continuing to win in the Middle East. 3. M.D.C. Holdings (MDC) upgraded to Buy from Sell at UBS with analyst Daniel Oppenheim saying he believes the company can lift its return on equity to 12.0% in 2019 driven by recent investments in land and greater capital utilization. 4. Centennial Resource Development (CDEV) upgraded to Outperform from Market Perform at BMO Capital with analyst Dan McSpirit citing a valuation opportunity that is now in line with its Permian peers following some recent "sponsorship selling" for a company that is executing with a "top-tier" growth rate. 5. Noble Energy (NBL) upgraded to Buy from Hold at Argus with analyst Bill Selesky saying the company is positioned to benefit from "improving industry fundamentals, including reduced production from OPEC members." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/18
JRCO
03/21/18
INITIATION
Target $25
JRCO
Buy
Centennial Resource Development initiated with a Buy at Johnson Rice
Johnson Rice analyst Brian Corales initiated Centennial Resource Development with a Buy and $25 price target.
03/13/18
BMOC
03/13/18
UPGRADE
Target $22
BMOC
Outperform
Centennial Resource Development upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Dan McSpirit upgraded Centennial Resource Development to Outperform from Market Perform and kept his $22 price target. McSpirit cites a valuation opportunity that is now in line with its Permian peers following some recent "sponsorship selling" for a company that is executing with a "top-tier" growth rate.
03/21/18
JRCO
03/21/18
INITIATION
Target $25
JRCO
Buy
Centennial Resource Development initiated with a Buy at Johnson Rice
Johnson Rice started Centennial Resource Development with a Buy rating and $25 price target.
CRZO Carrizo Oil & Gas
$26.46

0.65 (2.52%)

03/01/18
JEFF
03/01/18
UPGRADE
Target $20
JEFF
Buy
Carrizo Oil & Gas upgraded to Buy from Hold at Jefferies
Jefferies analyst Mark Lear upgraded Carrizo Oil & Gas to Buy while lowering his price target for the shares to $20 from $24. The analyst sees value in the shares following the recent underperformance. The company's Eagle Ford wells are tracking ahead of the updated type curve while the oil macro backdrop coming out of the Q4 earnings season is improving, Lear tells investors in a research note. He believes the worst is behind Carrizo.
04/04/18
DBAB
04/04/18
INITIATION
Target $20
DBAB
Hold
Carrizo Oil & Gas initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Nitin Kumar started Carrizo Oil & Gas with a Hold rating and $20 price target.
04/09/18
HOWW
04/09/18
DOWNGRADE
HOWW
Sector Perform
Carrizo Oil & Gas downgraded to Sector Perform at Scotia Howard Weil
Scotia Howard Weil analyst Philip Stuart downgraded Carrizo Oil & Gas to Sector Perform from Outperform following the stock's jump in early April due to the involvement of activist Kimmeridge pushing for a sale or merger, as he does not feel that the company has enough scale in the Permian to attract any suitors for the overall company and does not see selling the Eagle Ford as a viable option.
03/01/18
03/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wendy's (WEN) upgraded to Neutral from Sell at UBS by analyst Dennis Geiger, who has greater confidence in the company's free cash flow targets and same-store-sales momentum following his firm's survey of quick service restaurants consumers. The survey showed improved brand perceptions for Wendy's, Geiger said. 2. Kellogg (K) upgraded to Overweight from Neutral at Piper Jaffray by analyst Michael Lavery, who believes the valuation is attractive given his expectations for 8%-9% three-year earnings growth. A cash build should allow for earnings "flexibility and/or upside with upside to our buybacks assumptions," Lavery said. He believes expectations for Kellogg look achievable and maybe beatable. The analyst is more bullish on the shares following a meeting with management. 3. Carrizo Oil & Gas (CRZO) upgraded to Buy from Hold at Jefferies by analyst Mark Lear, who sees value in the shares following the recent underperformance. The company's Eagle Ford wells are tracking ahead of the updated type curve while the oil macro backdrop coming out of the Q4 earnings season is improving, Lear said. He believes the worst is behind Carrizo. 4. Eaton (ETN) upgraded to Neutral from Underweight at JPMorgan by analyst Ann Duignan, who said the risk/reward is balanced ahead of the company's analyst day. 5. Macy's (M) upgraded to Buy from Hold at Gordon Haskett by analyst Chuck Grom, who sees a pathway for improved comps over the next couple of years. This, coupled with the 27% reduction in float over the past decade, "yields a model with tremendous torque" and the potential for earnings upside, Grom tells investors in a research note. The analyst, who states he fully appreciates the long-term secular argument against the department store vertical, likes Macy's risk/reward profile at current share levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HLX Helix Energy
$8.00

0.04 (0.50%)

01/16/18
BOFA
01/16/18
DOWNGRADE
BOFA
Underperform
Helix Energy downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Timna Tanners downgraded Helix Energy to Underperform and based on valuation cut its price target to $7.50 from $8.
04/26/18
04/26/18
UPGRADE
Target $9

Outperform
Helix Energy upgraded to Outperform on increased demand at Raymond James
As previously reported, Raymond James upgraded Helix to Outperform from Market Perform and established a $9 price target. Analyst Marshall Adkins said Helix reported a Q1 beat well above consensus and believes Robotics is poised to rebound on increasing trenching demand, growing backlog, and a decline in charter costs.
04/26/18
RAJA
04/26/18
UPGRADE
RAJA
Outperform
Helix Energy upgraded to Outperform from Market Perform at Raymond James
04/25/18
PIPR
04/25/18
UPGRADE
Target $9
PIPR
Overweight
Helix Energy upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Ian Macpherson upgraded Helix Energy to Overweight and raised his price target for the shares to $9 from $7.10. Helix "stands fairly unique amongst its peers in terms of the improving macro coalescing with a tangibly improving earnings outlook and a credible investment thesis," Macpherson tells investors in a research note. He says the company's valuation and balance sheet screen favorably.
OAS Oasis Petroleum
$11.94

0.135 (1.14%)

04/30/18
JEFF
04/30/18
INITIATION
Target $13
JEFF
Buy
Oasis Petroleum assumed with a Buy at Jefferies
Jefferies analyst Thomas Hughes assumed coverage of Oasis Petroleum with a Buy rating and $13 price target. The shares trading near historically low levels relative to the group creates an attractive opportunity, Hughes tells investors in a research note.
04/23/18
RHCO
04/23/18
DOWNGRADE
Target $9
RHCO
Sell
Oasis Petroleum downgraded to Sell at SunTrust on valuation
As reported earlier, SunTrust analyst Neal Dingmann downgraded Oasis Petroleum to Sell from Hold on valuation as part of his Q1 preview for companies with exposure to the Bakken Basin. Dingmann notes that while the company's core Bakken "acreage represents some of the best in the basin", he sees its Delaware basin program frac spread underperformance requiring the company to "sacrifice high-return Bakken development for Delaware drilling and completion". However, the analyst is positive on Whiting Petroleum (WLL), raising its price target to $60 from $44 and Continental Resources (CLR), raising its price target to $80 from $75, saying the Bakken well economics observed last year make those companies an "attractive alternative" to the Permian.
04/23/18
RHCO
04/23/18
DOWNGRADE
RHCO
Sell
Oasis Petroleum downgraded to Sell from Hold at SunTrust
05/10/18
BOFA
05/10/18
UPGRADE
BOFA
Neutral
Oasis Petroleum upgraded to Neutral from Underperform at BofA/Merrill
OMP Oasis Midstream Partners
$18.33

-0.02 (-0.11%)

10/16/17
MSCO
10/16/17
INITIATION
Target $22
MSCO
Overweight
Oasis Midstream Partners initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Tom Abrams initiated Oasis Midstream Partners with an Overweight rating and $22 price target, saying he sees the units as attractively valued given his expectation for 25% DCF/unit growth through 2020.
10/16/17
10/16/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX) initiated with a Hold at Aegis. 2. Best Inc. (BSTI) was initiated with a Buy at Deutsche Bank, Stifel, and Goldman Sachs, an Outperform at Credit Suisse, as well as an Overweight at KeyBanc. 3. Oasis Midstream Partners (OMP) was initiated with an Overweight at Morgan Stanley and JPMorgan, an Outperform at RBC Capital, a Buy at Citi and Goldman Sachs, as well as a Market Perform at Wells Fargo. 4. Zai Lab (ZLAB) was initiated with a Buy at Citi and a Neutral at JPMorgan. 5. Despegar.com (DESP) was initiated with a Neutral at UBS, an Overweight at KeyBanc, an Equal Weight at Morgan Stanley, and a Neutral at UBS. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/24/17
JRCO
10/24/17
INITIATION
JRCO
Buy
Oasis Midstream Partners initiated with a Buy at Johnson Rice
Johnson Rice analyst Georg Venturatos initiated Oasis Midstream Partners (OMP) with a Buy saying it offers attractive, visible growth, supported by a sizeable backlog of drop-down opportunities and organic growth through Oasis Petroleum (OAS) activity.
01/04/18
FBCO
01/04/18
INITIATION
FBCO
Neutral
Oasis Midstream Partners initiated with a Neutral at Credit Suisse
Credit Suisse analyst Kristina Kazarlan initiated Oasis Midstream Partners with a Neutral rating and a price target of $19. Kazarlan said this small-cap MLP with fewer immediate catalysts is fairly valued.
SRCE 1st Source
$52.82

0.3 (0.57%)

10/23/17
DADA
10/23/17
NO CHANGE
Target $53
DADA
Neutral
1st Source price target raised to $58 from $48 at DA Davidson
DA Davidson analyst Kevin Reevey raised his price target on 1st Source to $53 following Q3 results that showed 2.9% growth in spread income and a 6% growth in fee income. Reevey notes that strong loan originations were only slightly offset by paydowns, and net interest margins remained stable relative to prior quarter. The analyst maintains a Neutral rating to reflect the recent run-up in bank valuations.

TODAY'S FREE FLY STORIES

02:30
11/15/18
11/15
02:30
11/15/18
02:30
General news
FX Update: The Dollar has traded broadly softer »

FX Update: The Dollar has…

01:50
11/15/18
11/15
01:50
11/15/18
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

APTX

Aptinyx

$24.75

-0.76 (-2.98%)

21:40
11/14/18
11/14
21:40
11/14/18
21:40
Initiation
Aptinyx initiated at Cantor Fitzgerald »

Aptinyx initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$4.75

-0.42 (-8.12%)

21:39
11/14/18
11/14
21:39
11/14/18
21:39
Initiation
Ovid Therapeutics initiated at Cantor Fitzgerald »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AXSM

Axsome Therapeutics

$2.82

-0.07 (-2.42%)

21:38
11/14/18
11/14
21:38
11/14/18
21:38
Initiation
Axsome Therapeutics initiated at Cantor Fitzgerald »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNLI

Denali Therapeutics

$17.53

0.24 (1.39%)

21:37
11/14/18
11/14
21:37
11/14/18
21:37
Initiation
Denali Therapeutics initiated at Cantor Fitzgerald »

Denali Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$2.34

-0.07 (-2.90%)

21:35
11/14/18
11/14
21:35
11/14/18
21:35
Initiation
Otonomy initiated at Cantor Fitzgerald »

Otonomy initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AAPL

Apple

$186.81

-5.42 (-2.82%)

20:46
11/14/18
11/14
20:46
11/14/18
20:46
Hot Stocks
Apple supplier AMS AG discontinues FY18 targets »

Ams updates its fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WEI

Weidai

$0.00

(0.00%)

20:33
11/14/18
11/14
20:33
11/14/18
20:33
Syndicate
Weidai 4.5M share IPO priced at $10.00 »

The deal was priced at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CPB

Campbell Soup

$39.16

-0.1 (-0.25%)

20:31
11/14/18
11/14
20:31
11/14/18
20:31
Hot Stocks
Campbell Soup responds to ISS regarding board elections »

Campbell Soup issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CRM

Salesforce

$129.25

-2.93 (-2.22%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25
Periodicals
Breaking Periodicals news story on Salesforce »

Salesforce to accommodate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

WMT

Walmart

$101.58

-1.37 (-1.33%)

, JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

WMT

Walmart

$101.58

-1.37 (-1.33%)

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

BERY

Berry Global

$45.91

-0.49 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

BHVN

Biohaven Pharmaceutical

$33.70

-3.18 (-8.62%)

19:53
11/14/18
11/14
19:53
11/14/18
19:53
Recommendations
Biohaven Pharmaceutical analyst commentary at Piper Jaffray »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

LOXO

Loxo Oncology

$143.69

-15.62 (-9.80%)

19:51
11/14/18
11/14
19:51
11/14/18
19:51
Initiation
Loxo Oncology initiated at Raymond James »

Loxo Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

OCUL

Ocular Therapeutix

$5.06

-0.25 (-4.71%)

19:50
11/14/18
11/14
19:50
11/14/18
19:50
Initiation
Ocular Therapeutix initiated at Raymond James »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Dec

VYGR

Voyager Therapeutics

$11.25

-0.54 (-4.58%)

19:49
11/14/18
11/14
19:49
11/14/18
19:49
Upgrade
Voyager Therapeutics rating change at Raymond James »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GLPG

Galapagos NV

$103.79

1.03 (1.00%)

19:48
11/14/18
11/14
19:48
11/14/18
19:48
Initiation
Galapagos NV initiated at Raymond James »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COPY

CopyTele

$0.00

(0.00%)

19:47
11/14/18
11/14
19:47
11/14/18
19:47
Upgrade
CopyTele rating change at BMO Capital »

CopyTele upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.43

-0.04 (-0.19%)

19:40
11/14/18
11/14
19:40
11/14/18
19:40
Syndicate
VICI Properties 30M share Secondary priced at $21.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

WHD

Cactus

$32.37

-0.7 (-2.12%)

19:37
11/14/18
11/14
19:37
11/14/18
19:37
Hot Stocks
Cactus names Stephen Tadlock new CFO »

Cactus announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVLT

Revolution Lighting

$1.42

(0.00%)

19:32
11/14/18
11/14
19:32
11/14/18
19:32
Hot Stocks
Revolution Lighting receives revised $1.50 per share proposal from RVL LLC »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$8.34

-0.265 (-3.08%)

19:20
11/14/18
11/14
19:20
11/14/18
19:20
Periodicals
General Electric withdraws from Nigeria rail concession, Reuters says »

GE has withdrawn from a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCSF

Bain Capital Specialty Finance

$0.00

(0.00%)

19:11
11/14/18
11/14
19:11
11/14/18
19:11
Syndicate
Bain Capital Specialty Finance 7.5M share IPO price $20.25 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TSLA

Tesla

$344.07

5.36 (1.58%)

19:07
11/14/18
11/14
19:07
11/14/18
19:07
Periodicals
Tesla Model 3 owners experience issues in cold weather, Electrek says »

Tesla Model 3 will face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 19

    Nov

  • 13

    Dec

NGHC

National General

$24.75

-3.05 (-10.97%)

19:05
11/14/18
11/14
19:05
11/14/18
19:05
Syndicate
National General 5M share Secondary priced at $24.00 »

JPMorgan, Goldman Sachs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.